{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T13:43:14Z","timestamp":1777470194360,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.clinthera.2018.05.002","type":"journal-article","created":{"date-parts":[[2018,5,26]],"date-time":"2018-05-26T03:13:19Z","timestamp":1527304399000},"page":"918-924.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Use of Galactomannan Antigen and Aspergillus DNA Real-time Polymerase Chain Reaction as Routine Methods for Invasive Aspergillosis in Immunosuppressed Children in Greece"],"prefix":"10.1016","volume":"40","author":[{"given":"Georgia","family":"Vrioni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalliopi","family":"Theodoridou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Costas","family":"Tsiamis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Mavrouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Violeta","family":"Kapsimali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Rigopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Tsakris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2018.05.002_bib1","doi-asserted-by":"crossref","unstructured":"Chen S, Sorrell T, Meyer W. Aspergillus and Penicillium. In: Jorgensen J, et al (eds) Manual of Clinical Microbiology. Vol. 2. Washington, DC 2015:2030-2056.","DOI":"10.1128\/9781555817381.ch119"},{"key":"10.1016\/j.clinthera.2018.05.002_bib2","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1086\/513943","article-title":"Invasive aspergillosis","volume":"26","author":"Denning","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2018.05.002_bib3","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1148\/radiographics.21.4.g01jl03825","article-title":"Spectrum of pulmonary aspergillosis: histologic, clinical, and radiologic findings","volume":"21","author":"Franquet","year":"2001","journal-title":"Radiographics"},{"key":"10.1016\/j.clinthera.2018.05.002_bib4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0732-8893(99)00026-7","article-title":"Epidemiology of nosocomial fungal infections: invasive aspergillosis and the environment","volume":"34","author":"VandenBergh","year":"1999","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.clinthera.2018.05.002_bib5","series-title":"Bennett & Brachman\u2019s Hospital Infections","first-page":"667","article-title":"Healthcare-associated fungal infections","author":"Smith","year":"2014"},{"key":"10.1016\/j.clinthera.2018.05.002_bib6","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1001\/jama.1979.03300150029022","article-title":"Aspergillosis and other systematic mycoses. The growing problem","volume":"242","author":"Fraser","year":"1979","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2018.05.002_bib7","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/jcp.44.6.452","article-title":"10 Years review of invasive aspergillosis detected at necropsy","volume":"44","author":"Boon","year":"1991","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.clinthera.2018.05.002_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1749-6632.2012.06805.x","article-title":"Invasive aspergillosis in the intensive care unit","volume":"1272","author":"Dimopoulos","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.clinthera.2018.05.002_bib9","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/MPH.0b013e3181b83e77","article-title":"Prospective monitoring for invasive aspergillosis using galactomannan and polymerase chain reaction in high risk patients","volume":"31","author":"Armenian","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.clinthera.2018.05.002_bib10","series-title":"Diagnostic performance of Aspergillus galactomannan antigen and Real-Time PCR detection among children with haematological malignancies","author":"Vrioni","year":"2017"},{"key":"10.1016\/j.clinthera.2018.05.002_bib11","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/eci.12448","article-title":"Diagnosis of invasive aspergillosis: recent developments and ongoing","volume":"45","author":"Arvanitis","year":"2015","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.clinthera.2018.05.002_bib12","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1600-0609.2012.01806.x","article-title":"Diagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan ELISA in bronchoalveolar lavage samples","volume":"89","author":"Reinwald","year":"2012","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clinthera.2018.05.002_bib13","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from European Organization for the Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG)","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2018.05.002_bib14","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1128\/JCM.01767-09","article-title":"Aspergillus PCR: one step closer to standardization","volume":"48","author":"Lewis","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.clinthera.2018.05.002_bib15","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(13)70076-8","article-title":"Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial","volume":"13","author":"Morrissey","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.clinthera.2018.05.002_bib16","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/myc.12322","article-title":"Potential of polymerase chain reaction and galactomannan for the diagnosis of invasive aspergillosis in patients with febrile neutropenia","volume":"58","author":"Aslan","year":"2015","journal-title":"Mycoses"},{"key":"10.1016\/j.clinthera.2018.05.002_bib17","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1086\/425317","article-title":"Utility of Aspergillus antigen detection in specimens other than serum specimens","volume":"39","author":"Klont","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2018.05.002_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007394","article-title":"Galactomannan detection for invasive aspergillosis in immunocomprised patients","volume":"4","author":"Leeflang","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinthera.2018.05.002_bib19","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/503427","article-title":"Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis","volume":"42","author":"Pfeiffer","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2018.05.002_bib20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2018.05.002_bib21","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/mmy\/myu025","article-title":"Performance of MycAssay Aspergillus DNA real-time PCR assay compared with the galactomannan detection assay for the diagnosis of invasive aspergillosis from serum samples","volume":"52","author":"Danylo","year":"2014","journal-title":"Med Mycol"},{"key":"10.1016\/j.clinthera.2018.05.002_bib22","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1128\/JCM.05026-11","article-title":"Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay","volume":"49","author":"Torelli","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.clinthera.2018.05.002_bib23","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/cid\/cir179","article-title":"High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease","volume":"52","author":"Denning","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2018.05.002_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1185\/03007995.2012.761134","article-title":"Fungal diagnosis: how do we do it and can we do better?","volume":"29","author":"Perfect","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2018.05.002_bib25","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1378\/chest.10-0488","article-title":"Accuracy of BAL galactomannan in diagnosing invasive aspergillosis: a bivariate metaanalysis and systematic review","volume":"138","author":"Guo","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.clinthera.2018.05.002_bib26","doi-asserted-by":"crossref","first-page":"e43347","DOI":"10.1371\/journal.pone.0043347","article-title":"Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis","volume":"7","author":"Zou","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clinthera.2018.05.002_bib27","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/pbc.24363","article-title":"Aspergillus galactomannan antigen assay and invasive Aspergillosis in pediatric cancer and hematopoietic stem cell transplant recipients","volume":"60","author":"Choi","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.clinthera.2018.05.002_bib28","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/jac\/dkn308","article-title":"False positivity of the Aspergillus galactomannan Platelia ELISA because of piperacillin\/tazobactam treatment: does it represent a clinical problem?","volume":"62","author":"Orlopp","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2018.05.002_bib29","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1128\/JCM.44.2.389-394.2006","article-title":"Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders","volume":"44","author":"Aubry","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.clinthera.2018.05.002_bib30","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1093\/jac\/dks111","article-title":"Piperacillin\/tazobactam (Tazocin\u2122) seems to be no longer responsible for false-positive results of the galactomannan assay","volume":"67","author":"Mikulska","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2018.05.002_bib31","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1128\/JCM.01365-14","article-title":"PCR in diagnosis of invasive aspergillosis: a meta-analysis of diagnostic performance","volume":"52","author":"Arvanitis","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.clinthera.2018.05.002_bib32","unstructured":"European Aspergillus PCR Initiative (EAPCRI) Working Group. http:\/\/www.eapcri.eu\/ [Last accessed 24 January 2018]"},{"key":"10.1016\/j.clinthera.2018.05.002_bib33","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1128\/CMR.00091-13","article-title":"Molecular and nonmolecular diagnostic methods for invasive fungal infections","volume":"27","author":"Arvanitis","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.clinthera.2018.05.002_bib34","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/cid\/civ555","article-title":"Galactomannan and polymerase chain reaction-based screening for invasive aspergillosis among high-risk hematology patients: a diagnostic meta-analysis","volume":"61","author":"Arvanitis","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2018.05.002_bib35","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291818301887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291818301887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T21:58:05Z","timestamp":1529099885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291818301887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0149291818301887"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2018.05.002","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Galactomannan Antigen and Aspergillus DNA Real-time Polymerase Chain Reaction as Routine Methods for Invasive Aspergillosis in Immunosuppressed Children in Greece","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2018.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}